HUMAW - Humacyte targets over 200 hospital access points for Symvess as VAC approvals surge and cost cuts extend cash runway
2025-08-11 10:01:36 ET
More on Humacyte
- Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript
- Humacyte: Revenue Ramp From Symvess Incoming
- Humacyte Paradoxically Scales Back As Symvess Begins Its Long Journey
- Humacyte GAAP EPS of -$0.24 misses by $0.08, revenue of $0.3M misses by $0.7M
- Humacyte rises on Symvess sale to military treatment facility